ID

34387

Descrição

Influence of Probiotics Administration Before Liver Resection in Liver Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02021253

Link

https://clinicaltrials.gov/show/NCT02021253

Palavras-chave

  1. 17/01/2019 17/01/2019 -
  2. 07/10/2020 07/10/2020 -
Titular dos direitos

see on clinicaltrials.gov

Transferido a

17 de janeiro de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Liver Fibrosis NCT02021253

Eligibility Liver Fibrosis NCT02021253

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
agreement signed by the patient
Descrição

ID.1

Tipo de dados

boolean

diagnosis of hcc confirmed
Descrição

ID.2

Tipo de dados

boolean

diagnosis of liver disease (score f3 or f4) confirmed
Descrição

ID.3

Tipo de dados

boolean

indication of surgical resection confirmed and validated by a specialist multidisciplinary assessment meeting of gastrointestinal oncology
Descrição

ID.4

Tipo de dados

boolean

patient operable (no indication against anaesthesiological)
Descrição

ID.5

Tipo de dados

boolean

resectable tumor lesion (surgical expertise)
Descrição

ID.6

Tipo de dados

boolean

laboratory tests and endoscopy: no suspicion of severe portal hypertension with bleeding risk
Descrição

ID.7

Tipo de dados

boolean

Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient not willing, at risk of default of compliance, or patient can not be monitored regularly
Descrição

ID.8

Tipo de dados

boolean

antibiotic extended or terminated for less than 1 month, may limit the effects of taking probiotics.
Descrição

ID.9

Tipo de dados

boolean

inflammatory bowel disease, which could skew the results expected by taking probiotics results.
Descrição

ID.10

Tipo de dados

boolean

Similar models

Eligibility Liver Fibrosis NCT02021253

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
agreement signed by the patient
boolean
ID.2
Item
diagnosis of hcc confirmed
boolean
ID.3
Item
diagnosis of liver disease (score f3 or f4) confirmed
boolean
ID.4
Item
indication of surgical resection confirmed and validated by a specialist multidisciplinary assessment meeting of gastrointestinal oncology
boolean
ID.5
Item
patient operable (no indication against anaesthesiological)
boolean
ID.6
Item
resectable tumor lesion (surgical expertise)
boolean
ID.7
Item
laboratory tests and endoscopy: no suspicion of severe portal hypertension with bleeding risk
boolean
Item Group
C0680251 (UMLS CUI)
ID.8
Item
patient not willing, at risk of default of compliance, or patient can not be monitored regularly
boolean
ID.9
Item
antibiotic extended or terminated for less than 1 month, may limit the effects of taking probiotics.
boolean
ID.10
Item
inflammatory bowel disease, which could skew the results expected by taking probiotics results.
boolean

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial